A recent large study conducted in Sweden has found that long-term exposure to elevated levels of air pollution may increase ...
The first patient has been dosed in a Phase 1/2 clinical study of VTx-002, an experimental therapy for amyotrophic lateral sclerosis.
IV edaravone-treated patient had longer disease progression milestone-free time for all 6 milestones compared with control. Treatment with intravenous (IV) edaravone was associated with fewer reported ...
Half of the planned 200 ALS patients have joined Medicinova’s expanded access program evaluating the experimental drug MN-166.
Please provide your email address to receive an email when new articles are posted on . The treatment group logged longer times to four disease-progression milestones compared with controls. At 2 ...
Please provide your email address to receive an email when new articles are posted on . A new analysis of an overall survival study of an investigational immunotherapy platform to treat ALS found it ...
13don MSN
Brooke Eby shares update in her ALS progression after she started 'choking more' in recent months
The TikTok star, 37, was officially diagnosed with the terminal neurodegenerative disease in 2022 ...
Amyotrophic lateral sclerosis (ALS) affects the nerve cells in the brain and spinal cord that control muscle movement. Different types of ALS cause symptoms to begin in a certain part of the body and ...
ALS is a progressive disease, meaning it worsens over time. Although there is no cure for ALS, medications and therapies are available to help manage the symptoms, slow the disease course, and prolong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results